Elocon vs Fluticasone in Localized Psoriasis (P03197)
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, parallel-group clinical study. The primary objective is to
assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs
fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the
management of Indian patients with localized psoriasis.